Paul Edward Kelly - 05 Nov 2025 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Signature
/s/ Paul Kelly
Issuer symbol
RLMD
Transactions as of
05 Nov 2025
Net transactions value
+$198,000
Form type
4
Filing time
06 Nov 2025, 07:30:02 UTC
Previous filing
30 Jun 2025
Next filing
16 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kelly Paul Edward Chief Operating Officer, Director C/O RELMADA THERAPEUTICS, INC., 2222 PONCE DE LEON BLVD, 3RD FLOOR, CORAL GABLES, /s/ Paul Kelly 06 Nov 2025 0001658544

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Purchase $198,000 +90,000 +22% $2.20 502,295 05 Nov 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.